The Combined Effect of Nonalcoholic Fatty Liver Disease and Metabolic Syndrome on Osteoporosis in Postmenopausal Females in Eastern China

Table 2

Multivariate analyses of associations between osteoporosis and clinical features in postmenopausal females.

Characteristics	Model 1		Model 2
	Osteoporosis (+) versus osteoporosis (−)		Osteoporosis (+) versus osteoporosis (−)
	OR (95% CI)	value	OR (95% CI)	value
Age (years)	1.241 (1.021–1.347)	0.019	1.114 (1.113–1.441)	0.015
TC (mmol/l)	1.314 (0.983–1.572)	0.291	1.243 (0.919–1.472)	0.324
ALP	1.104 (1.031–1.447)	0.029	1.311 (0.891–1.532)	0.112
NAFLD	1.664 (0.989–3.117)	0.121
SNAFLD			3.316 (1.389–6.717)	0.001
MetS	3.164 (1.281–5.213)	0.002	2.964 (1.319–4.917)	0.005

TC: serum total cholesterol; ALP: alkaline phosphatase; NAFLD: nonalcoholic fatty liver disease; SNAFLD: significant nonalcoholic fatty liver disease; MetS: metabolic syndrome; OR: odds ratio; CI: confidence interval. Note: represents value < 0.05.